Artificial Cornea
Eyegenix™ is the world’s most advanced biosynthetic cornea. Cornea transplantation is the most common human transplant surgery performed in the world today. However, due to a global shortage of organ donors, especially in Asia, less than 2% of blind patients are able to receive a transplant. Eyegenix brings the hope of creating an infinite supply of artificial corneas to restore vision for the world’s estimated 10 million people with corneal blindness.
*Eyegenix is a sister company of SKAI Ventures.
